TScan Therapeutics, Inc. (TCRX)

USD 1.12

(1.82%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 21.04 Million 13.53 Million 10.14 Million 1.08 Million -
Cost of Revenue 88.15 Million 5.13 Million 3.32 Million 20.57 Million 519 Thousand
Gross Profit -67.1 Million 8.39 Million 6.81 Million -19.49 Million -519 Thousand
Operating Expenses 114.5 Million 80.17 Million 58.78 Million 27.31 Million 14.21 Million
Selling, General and Administrative Expenses 26.35 Million 20.35 Million 13.82 Million 6.74 Million 4.76 Million
Research and Development Expenses 88.15 Million 59.81 Million 44.95 Million 20.57 Million 9.44 Million
Other Expenses - 1.59 Million 16 Thousand - -
Cost and Expenses 114.5 Million 80.17 Million 58.78 Million 27.31 Million 14.21 Million
Operating Income -93.45 Million -66.63 Million -48.64 Million -26.23 Million -14.21 Million
Interest Expense 3.75 Million 1.17 Million - - -
Income Tax Expense - -415 Thousand 3.09 Million -106 Thousand -552 Thousand
Earnings before Tax -89.21 Million -66.22 Million -48.62 Million -26.12 Million -13.65 Million
Net Income -89.21 Million -65.8 Million -48.62 Million -26.02 Million -13.1 Million
Earnings Per Share Basic -1.36 -2.74 -2.03 -1.04 -0.53
Earnings Per Share Diluted -1.36 -2.74 -2.03 -1.04 -0.53
Weighted Average Shares Outstanding 65.59 Million 24.04 Million 23.9 Million 24.93 Million 24.93 Million
Weighted Average Shares Outstanding (Diluted) 65.59 Million 24.04 Million 23.9 Million 24.93 Million 24.93 Million
Gross Margin -3.19 0.62 0.67 -17.96 -
EBIT Margin -3.81 -4.81 -4.47 -23.04 -
Profit Margin -4.24 -4.86 -4.79 -23.98 -
EBITDA -80.09 Million -59.9 Million -45.29 Million -25 Million -13.69 Million
Earnings Before Tax Margin -4.44 -4.92 -4.80 -24.18 -

Income Statement Charts